INTERCEPT PHARMACEUTICALS INC financial statements, including revenue, expenses, profit, and loss
The total revenue of ICPT for the last quarter is 1.55 B MXN, and it's 7.85% higher compared to the previous quarter. The net income of Q3 23 is -48.11 M MXN.